---
title: "Dr Natalie Laura Curtis — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1cd4cb76-e7eb-5cba-9f83-9528c3b22513
json: https://whiteintel.dev/api/public/dossier/1cd4cb76-e7eb-5cba-9f83-9528c3b22513
identifier: oo-person:GB-COH-PER-13886983-zDvYeSazCwiR7xTg65IwQUecOUc
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Dr Natalie Laura Curtis

**Type:** Person  
**Jurisdiction:** GB  
**Identifier:** `oo-person:GB-COH-PER-13886983-zDvYeSazCwiR7xTg65IwQUecOUc`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/1cd4cb76-e7eb-5cba-9f83-9528c3b22513  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1cd4cb76-e7eb-5cba-9f83-9528c3b22513  

## Ownership & control

### Holdings / subsidiaries

- **OXFORD TARGET THERAPEUTICS LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/ba678530-0217-554c-944f-47f0edfa4e76

## Provenance

- OpenOwnership — https://www.openownership.org

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Dr Natalie Laura Curtis**. Human view: https://whiteintel.dev/entity/1cd4cb76-e7eb-5cba-9f83-9528c3b22513 · Structured JSON: https://whiteintel.dev/api/public/dossier/1cd4cb76-e7eb-5cba-9f83-9528c3b22513._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._